117 Publications (Page 4 of 5)
2006
Immunologic approaches to acute leukemia in the elderly.
Farag, Sherif S and Caligiuri, Michael A
Seminars in hematology, vol. 43, (no. 2), pp. 118-25, 2006/Apr. | Journal Article
 
Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation.
Wadehra, Navin⋅Farag, Sherif S⋅Bolwell, Brian⋅Elder, Patrick⋅Penza, Sam L⋅Kalaycio, Matt⋅Avalos, Belinda⋅Pohlman, Brad⋅Marcucci, Guido⋅Sobecks, Ronald⋅Lin, Thomas⋅Andrèsen, Steven and Copelan, Edward
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol. 12, (no. 12), pp. 1343-9, 2006/Dec. | Journal Article
 
OSU03012, a Novel Celecoxib Derivative, Induces Apoptosis in Multiple Myeloma Cells Independently of Caspase Activation
Zhang, Shuhong⋅Zhang, Shuhong⋅White, Valerie L⋅White, Valerie L⋅Johnson, Amy⋅Johnson, Amy⋅Chen, Ching-Shih⋅Chen, Ching-Shih⋅Farag, Sherif S and Farag, Sherif S
Blood, vol. 108, (no. 11), pp. 5075, 2006-11-16. | Journal Article
 
OSU-HDAC42, a Novel Histone Deacetylase Inhibitor, Induces Apoptosis in a Caspase-Dependent Manner and Induces p21WAF1/CIP1 and p16 Expression in Multiple Myeloma Cell Lines
White, Valerie L⋅White, Valerie L⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Lucas, David⋅Lucas, David⋅Chen, Ching-Shih⋅Chen, Ching-Shih⋅Farag, Sherif S and Farag, Sherif S
Blood, vol. 108, (no. 11), pp. 5078, 2006-11-16. | Journal Article
 
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.
Farag, Sherif S⋅Archer, Kellie J⋅Mrózek, Krzysztof⋅Ruppert, Amy S⋅Carroll, Andrew J⋅Vardiman, James W⋅Pettenati, Mark J⋅Baer, Maria R⋅Qumsiyeh, Mazin B⋅Koduru, Prasad R⋅Ning, Yi⋅Mayer, Robert J⋅Stone, Richard M⋅Larson, Richard A⋅Bloomfield, Clara D⋅Vardiman, James W⋅Pettenati, Mark J⋅Baer, Maria R⋅Qumsiyeh, Mazin B⋅Koduru, Prasad R⋅Ning, Yi⋅Mayer, Robert J⋅Farag, Sherif S⋅Carroll, Andrew J⋅Mrózek, Krzysztof⋅Larson, Richard A⋅Archer, Kellie J⋅Bloomfield, Clara D⋅Stone, Richard M and Ruppert, Amy S
Blood, vol. 108, (no. 1), pp. 63-73, 2006/Jul/1. | Journal Article
 
The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
Farag, Sherif S⋅Farag, S.S.⋅Bacigalupo, Andrea⋅Bacigalupo, A.⋅Eapen, Mary⋅Eapen, M.⋅Hurley, Carolyn⋅Hurley, C.⋅Dupont, B.⋅Dupont, Bo⋅Caligiuri, M.A.⋅Caligiuri, Michael A⋅Boudreau, Christian⋅Boudreau, C.⋅Nelson, Gene⋅Nelson, G.⋅Oudshoorn, M.⋅Oudshoorn, Machteld⋅van Rood, Jon⋅Rood, J.⋅Velardi, A.⋅Velardi, Andrea⋅Maiers, M.⋅Maiers, Martin⋅Setterholm, Michelle⋅Setterholm, M.⋅Confer, Dennis⋅Confer, D.⋅Posch, Phillip E⋅Posch, P.E.⋅Anasetti, Claudio⋅Anasetti, C.⋅Kamani, N.⋅Kamani, Naynesh⋅Miller, J.S.⋅Miller, Jeffrey S⋅Weisdorf, Daniel⋅Weisdorf, D.⋅Davies, S.M. and Davies, Stella M
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol. 12, (no. 8), pp. 876-84, 2006/Aug. | Journal Article
2005
DC therapy? Let the natural killer answer
Farag, Sherif S
Blood, vol. 106, (no. 6), pp. 1892, 2005-09-15. | Journal Article
 
Diffuse alveolar hemorrhage following gemtuzumab ozogamicin
Lin, Thomas S⋅Penza, Sam L⋅Avalos Copelan, Belinda⋅Lucarelli, Maria R⋅Farag, Sherif S⋅Byrd, John C and Copelan, Edward A
Bone Marrow Transplantation, vol. 35, (no. 8), pp. 823-4, Apr 2005. | Journal Article
 
FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia.
Lin, Thomas S⋅Flinn, Ian W⋅Modali, Rama⋅Lehman, Teresa A⋅Webb, Jennifer⋅Waymer, Sharon⋅Moran, Mollie E⋅Lucas, Margaret S⋅Farag, Sherif S and Byrd, John C
Blood, vol. 105, (no. 1), pp. 289-91, 2005/Jan/1. | Journal Article
 
Flavopiridol, Fludarabine and Rituximab Is a Highly Active Regimen in Indolent B-Cell Lymphoproliferative Disorders Including Mantle Cell Lymphoma
Lin, Thomas S⋅Fischer, Beth⋅Moran, Mollie E⋅Buckner, Maureen M⋅Shank, Roshini⋅Kraut, Eric H⋅Porcu, Pierluigi⋅Farag, Sherif S⋅Eisenbeis, Charles F⋅Colevas, Dimitrios⋅Grever, Michael R and Byrd, John C
Blood, vol. 106, (no. 11), pp. 944, 2005-11-16. | Journal Article
 
High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia
Farag, Sherif S⋅Bolwell, B. J⋅Elder, P. J⋅Kalaycio, M.⋅Lin, T.⋅Pohlman, B.⋅Penza, Sam L⋅Marcucci, Guido⋅Blum, William⋅Sobecks, Ronald M⋅Avalos Copelan, Belinda⋅Byrd, John C and Copelan, Edward A
Bone Marrow Transplantation, vol. 35, (no. 7), pp. 653-61, Apr 2005. | Journal Article
 
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.
Farag, Sherif S⋅Ruppert, Amy S⋅Mrózek, Krzysztof⋅Mayer, Robert J⋅Stone, Richard M⋅Carroll, Andrew J⋅Powell, Bayard L⋅Moore, Joseph O⋅Pettenati, Mark J⋅Koduru, Prasad R⋅Stamberg, Judith⋅Baer, Maria R⋅Block, Annemarie⋅Vardiman, James W⋅Kolitz, Jonathan E⋅Schiffer, Charles A⋅Larson, Richard A and Bloomfield, Clara D
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 23, (no. 3), pp. 482-93, 2005/Jan/20. | Journal Article
 
Phase II study of topotecan and cyclophosphamide in patients with relapsed and refractory multiple myeloma
Kraut, Eric H⋅Kraut, Eric H⋅Young, Donn⋅Young, Donn⋅Farag, Sherif⋅Farag, Sherif⋅James, Arthur G⋅James, Arthur G⋅Solove, Richard J and Solove, Richard J
Leukemia Research, vol. 29, (no. 10), pp. 1234, 2005. | Journal Article
2004
Chronic graft-versus-host disease: where do we go from here?
Farag, S
Bone Marrow Transplantation, vol. 33, (no. 6), pp. 569-77, Mar 2004. | Journal Article
 
Cytokine modulation of the innate immune system in the treatment of leukemia and lymphoma.
Farag, Sherif S and Caligiuri, Michael A
Advances in pharmacology (San Diego, Calif.), vol. 51, pp. 295-318, 2004. | Journal Article
 
Depletion of alloreactive T cells: which cell?
Farag, Sherif S
Blood, vol. 104, (no. 12), pp. 3423, 2004-12-01. | Journal Article
 
Fc gamma RIIIa and Fc gamma RIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia.
Farag, Sherif S⋅Flinn, Ian W⋅Modali, Rama⋅Lehman, Teresa A⋅Young, Donn C and Byrd, John C
Blood, vol. 103, (no. 4), pp. 1472-4, 2004/Feb/15. | Journal Article
 
Immunotherapeutic strategies of stem cell transplant in lymphoma
Farag, Sherif S
Clinical advances in hematology & oncology : H&O, vol. 2, (no. 10), pp. 638, 2004-Oct. | Journal Article
 
Pre-Treatment Cytogenetics Predict Complete Remission and Long-Term Outcome in Patients (Pts) ≥60 Years with Acute Myeloid Leukemia (AML): Results from Cancer and Leukemia Group B (CALGB) 8461
Farag, Sherif S⋅Archer, Kellie J⋅Mrózek, Krzysztof⋅Vardiman, James W⋅Carroll, Andrew J⋅Pettenati, Mark J⋅Powell, Bayard L⋅Moore, Joseph O⋅Kolitz, Jonathan E⋅Baer, Maria R⋅Bigner, Sandra H⋅Koduru, Prasad R⋅Stamberg, Judith⋅Mayer, Robert J⋅Stone, Richard M⋅Schiffer, Charles A⋅Larson, Richard A and Bloomfield, Clara D
Blood, vol. 104, (no. 11), pp. 568, 2004-11-16. | Journal Article
 
Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study.
Farag, Sherif S⋅Ruppert, Amy S⋅Mrózek, Krzysztof⋅Carroll, Andrew J⋅Pettenati, Mark J⋅Le Beau, Michelle M⋅Peterson, Bercedis⋅Powell, Bayard L⋅Ozer, Howard⋅Silver, Richard T⋅Larson, Richard A and Bloomfield, Clara D
International Journal of Oncology, vol. 25, (no. 1), pp. 143-51, 2004/Jul. | Journal Article
 
Single Institution Experience with Two High-Dose Chemotherapy (HDC) Conditioning Regimens Prior to Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM)
Benson, Don M⋅Elder, Patrick J⋅Lin, Thomas⋅Blum, William⋅Penza, Sam⋅Avalos, Belinda⋅Byrd, John C⋅Copelan, Edward and Farag, Sherif S
Blood, vol. 104, (no. 11), pp. 5214, 2004-11-16. | Journal Article
 
Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation
Copelan, Edward A⋅Hoshaw-Woodard, S.⋅Elder, P.⋅Penza, Sam L⋅Farag, Sherif S⋅Marcucci, Guido⋅Lin, T.⋅Ezzone, S.⋅Scholl, M. D⋅Bechtel, T.⋅Lemeshow, Stanley and Avalos Copelan, Belinda
Bone Marrow Transplantation, vol. 34, (no. 1), pp. 85-87, Jul 2004. | Journal Article
2003
Biology and clinical impact of human natural killer cells.
Farag, Sherif S⋅VanDeusen, Jeffrey B⋅Fehniger, Todd A and Caligiuri, Michael A
International Journal of Hematology, vol. 78, (no. 1), pp. 7-17, 2003/Jul. | Journal Article
 
Monoclonal antibodies for the prevention and treatment of graft-versus-host disease
Bruner, Rebecca J⋅Bruner, Rebecca J⋅Farag, Sherif S and Farag, Sherif S
Seminars in Oncology, vol. 30, (no. 4), pp. 519, August 2003. | Journal Article
 
New directions in natural killer cell-based immunotherapy of human cancer.
Farag, Sherif S⋅Fehniger, Todd A⋅Becknell, Brian⋅Blaser, Bradley W and Caligiuri, Michael A
Expert Opinion on Biological Therapy, vol. 3, (no. 2), pp. 237-50, 2003/Apr. | Journal Article